with Correct and Verified Answers
There are several physiologic abnormalities that may result in ambiguous genitalia and/or an
unclear sense of gender identity leading to gender dysphoria. When an adolescent female is
found to have cryptorchid testes, this indicates a condition known as: - Correct Answer A.
Congenital adrenal hyperplasia
B. Androgen insensitivity syndrome
C. Turner's syndrome
D. Klinefelter's syndrome
Which of the following is a true statement with respect to developmental coordination
disorder? - Correct Answer A. The majority of children with this disorder do not have a history
of significant developmental milestone delay.
B. The clumsiness of developmental disorder generally persists into adolescence and
adulthood.
C. Most successful treatment strategies involve integrative physical education to include the
peer group in team sports.
D. Neurologic examination is very similar to patients with neuromuscular disease.
Donna is a 16-year-old transgender female who has been through extensive individual and
family counseling and is ready to start hormone therapy with estrogen, progesterone, and
testosterone-blocking agents. When counseling her specifically about the risks, benefits,
and required monitoring of hormonal therapy, the PMHNP advises Donna that: - Correct
Answer A. Her voice will become more consistent with the female gender
B. She will need routine lipid and diabetes screening
C. Sterility is a probable consequence of hormone therapy
D. Worsening of acne is common in the first year of treatment
The difference between hormonal management of transgender adolescents from adults is
that which of the following has no role in adult management? - Correct Answer A. Estrogen
B. Gonadotropin-releasing hormone
C. Testosterone
D. Testosterone blockers
Jessica is a 26-month-old female who is being evaluated because she will not eat. Her
parents report that she just flat out will not eat her meals. Her mother says that she has
followed all the pediatrician's suggestions: she has eliminated any snacks or drinks between
meals, and she has offered a variety of foods, including those that Jessica seemed to enjoy
,previously. Jessica is not sick; has no problems with vomiting or elimination abnormalities.
Jessica's parent say that her pediatrician is not concerned, but they are not comfortable with
what appears to be an almost complete absence of food intake. While considering a
diagnosis of avoidant food intake disorder the PMHNP knows that any of the following would
fulfill the diagnostic criteria except: - Correct Answer A. An irritable, apathetic, or anxious
affect
B. Failure to gain weight consistent with her trajectory since birth
C. A loss of 15% body weight
D. Use of daily nutritional supplements
Christine is a 9-year-old female who presents for care after having been placed in the local
foster care system. She has been in and out of foster care for the last 4 years after her
parents were killed in an automobile accident. Christine has been placed in a variety of
homes and residential care facilities. The PMHNP recognizes that Christine is at high risk for:
- Correct Answer A. Dissociative disorders
B. Post-traumatic stress disorder
C. Impulse-control disorder
D. Attachment disorder
Caylee is a 5-year-old girl who is referred for evaluation by child protective services. She was
recently removed from her biological family and placed in foster care, as her home
environment was reportedly unsafe due to conditions of extreme neglect. Her foster mother
reports that Caylee is very quiet and withdrawn and always appears sad and disinterested in
her surroundings; however, she becomes very irritable when anything unexpected or
unplanned occurs. The foster mother became very concerned when it appeared that Caylee
was hallucinating. The PMHNP considers that: - Correct Answer A. Caylee is at high risk for
suicide and precautions should be taken
B. The hallucinations are consistent with brief psychotic disorder or schizophrenia
C. The history and reported symptoms are typical of depressive disorder in young children
D. This is a common situation when prepubertal children are removed from the biological
parents regardless of how dysfunctional they are
Debi is a 15-year-old girl who is currently being treated for depression. Her parents have
been very proactive and involved in her care, and Debi has achieved remission 2 months after
beginning treatment with a combination of pharmacotherapy and cognitive behavioral
therapy. While counseling Debi's parents about important issues in management, the PMHNP
advises that: - Correct Answer A. There is a > 50% likelihood that Debi's younger sibling will
develop depressive symptoms
B. The mean length of major depressive episode in adolescents is 4 months
C. 20 to 40% of adolescents who have major depressive disorder will develop bipolar I within
5 years
D. Adolescent-onset depression typically need long-term pharmacologic management to
prevent relapses
Agomelatine - Correct Answer Brand: Valdoxan
, -Melatonin multimodal (Mel-MM)
-Agonist at melatonergic 1 and melatonergic 2 receptors
-Antagonist at 5HT2C receptors
-Not FDA approved: Rx for Depression, Generalized anxiety disorder
-Initial 25 mg/day at bedtime; after 2 weeks can increase to 50 mg/day at bedtime
Amitriptyline (Elavil) - Correct Answer Tricyclic antidepressant.
Aripiprazole (Abilify) - Correct Answer Treatment for depression. Atypical antipsychotic.
"Dopamine stabilizer". Dopamine receptor antagonist in high concentration and also
stimulates increase of dopamine in low concentrations. Side effects: insomnia, akathisia.
Brexpiprazole (Rexulti) - Correct Answer Treatment for depression. Atypical antipsychotic
Bupropion (Wellbutrin) - Correct Answer Antidepressant and smoking cessation aid, It can
treat depression and help people quit smoking. It can also prevent depression caused by
seasonal affective disorder (SAD).
Citalopram (Celexa) - Correct Answer Antidepressant, SSRI: 20-40 mg qd.
Clomipramine (Anafranil) - Correct Answer -Serotonin reuptake inhibitor (S-RI)
-Tricyclic antidepressant (TCA)
-Parent drug is a potent serotonin reuptake inhibitor
Active metabolite is a potent norepinephrine/noradrenaline reuptake inhibitor
-Increases serotonergic neurotransmission by blocking the serotonin reuptake pump
(transporter), -Desensitization of serotonin receptors, especially serotonin 1A receptors
-Increases noradrenergic neurotransmission by blocking the norepinephrine reuptake pump
(transporter), -Desensitization of beta adrenergic receptors
-Dopamine is inactivated by norepinephrine reuptake in the frontal cortex
-Lacks dopamine transporters
-Increases dopamine neurotransmission in this part of the brain
**FDA Approved for Pediatrics in tx Obsessive-compulsive disorder (OCD) (ages 10 and older)
*Off-Label for Pediatric Use: Depression, Severe and treatment-resistant, depression,
Cataplexy syndrome, Anxiety, Insomnia,
Neuropathic pain/chronic pain
-Full therapeutic benefits may take 2-8 weeks
-Dosing: in Peds/Adolescents/Adults:
100-250mg/day
Cyamemazine (Tercian) - Correct Answer Treatment for depression.
-Known as cyamepromazine
-Typical antipsychotic drug of the phenothiazine class.
-Treatment for schizophrenia
and psychosis-associated